Oregon Bulletin
March 1, 2011
Rule
Caption: Renumber of Oregon Prescription
Drug Program rules.
Adm.
Order No.: DMAP 1-2011
Filed with Sec. of
State: 2-10-2011
Certified to be
Effective: 3-1-11
Notice Publication
Date:
Rules Renumbered: 409-030-0000 to 410-121-2000, 409-030-0005 to
410-121-2005, 409-030-0010 to 410-121-2010, 409-030-0020 to 410-121-2020,
409-030-0030 to 410-121-2030, 409-030-0050 to 410-121-2050, 409-030-0065 to
410-121-2065
Subject: Renumber of Oregon Prescription Drug Program rules to
update references consistent with agency organization from the Office of Oregon
Health Policy and Research (409) to the Division of Medical Assistance Programs
(410).
Rules Coordinator: Darlene Nelson—(503) 945-6927
410-121-2000
Definitions
(1) “340B” means Section 340B of the Public Health
Service Act, “Limitation on Prices of Drugs Purchased by Covered Entities,” and
any and all related rules, guidance, interpretations, and operational
directives adopted by the federal Health Resources and Services Administration
(HRSA) or any other governmental agency with jurisdiction over the enforcement
of Section 340B.
(2) “Administrator” means the Administrator of the
Oregon Prescription Drug Program (OPDP).
(3) “Critical Access Pharmacy (CAP)” means a sole Oregon
pharmacy in a community within a ten-mile radius from other pharmacies. If a
pharmacy’s ten-mile radius intersects with another sole pharmacy’s ten-mile
radius, both shall be considered a CAP if either pharmacy’s closure could
result in impaired access for rural communities.
(4) “Department” means the Department of Human
Services.
(5) “Designated Entity” means an entity contracted by
the Department to perform administrative duties of the program including but
not limited to determining program prices, processing and paying claims,
issuing identification cards, maintaining eligibility files, and performing
replenishment administration. Designated entities may include but are not
limited to pharmacy benefits managers, third party administrators, insurance
carriers, health maintenance organizations (HMOs), mail order and specialty
drug suppliers, replenishment administrators, group purchasing organizations,
and wholesalers.
(6) “Group Enrollee” means any individual who is issued
an OPDP identification card through a participating group.
(7) “Group Purchasing Organization (GPO)” means any
organization purchasing on a group basis for purchasers whose drug purchasing
is exempt from the federal price discrimination law known as the Robinson
Patman Act, 15 USC 13 and satisfies the Nonprofit Institutions Act, 15 USC 13c,
or is that of a governmental entity performing traditional government
functions.
(8) “Enrollee” means an individual who meets the
eligibility requirements of the OPDP according to ORS 414.312(e), pays the
applicable enrollment fee, and is issued an enrollment card.
(9) “Participating Group” means agencies or
institutions eligible to participate in the OPDP according to ORS 414.312(4).
(10) “Pharmacy Benefit Manager (PBM)” means an entity
that negotiates and executes contracts with pharmacies, manages preferred drug
lists (PDL), negotiates rebates with prescription drug manufacturers, and
serves as an intermediary between the Administrator, prescription drug
manufacturers, and pharmacies.
(11) “Pharmacy Provider” means retail drug outlets that
volunteer to participate in the OPDP and that contract with the Department or a
designated entity as a pharmacy provider.
(12) “Prescription Drug” means drugs whose sale without
a prescription is prohibited by law.
(13) “Prescription Drug Claims Processor” means an
entity that processes and pays prescription drug claims, transmits prescription
drug prices and claims data between pharmacies and the OPDP, and processes
payments to pharmacies.
(14) “Program Price” means the reimbursement rates and
prescription drug prices established by the OPDP Administrator directly or
through a contract with a designated entity, including program cost, dispensing
fee, and all applicable manufacturers discounts and rebates.
(15) “Rebate” means promotional or volume related
refunds pre-arranged with manufacturers on certain prescription drugs used to
reduce the cost to the purchaser.
(16) “Replenishment Administration” means tracking GPO
or 340B program usage by pharmacy and ordering replacement inventory including
associated reporting; GPO and 340B retail and mail order pharmacy contracting;
GPO and 340B contracting; or as otherwise defined by contract.
(17) “Third Party Administrator (TPA)” means an entity
that, in addition to being a prescription drug claims processor, facilitates
program management including processing and paying prescription drug claims;
transmitting prescription drug prices and claims and enrollment data between
pharmacies and the OPDP and its groups; maintaining enrollment and issuing
identification cards; and processing payments to pharmacies. The TPA may be
contracted through the Department or PBMs, or other designated entities.
Stat. Auth.: ORS 414.320
Stats. Implemented: ORS 414.312 -
414.320
Hist.: OHP 1-2004, f. & cert.
ef. 9-24-04; OHP 2-2006(Temp), f. & cert. ef. 11-28-06 thru 5-23-07; OHP
2-2007(Temp), f. & cert. ef. 5-16-07 thru 11-6-07; OHP 3-2007, f. &
cert. ef. 8-3-07; OHP 3-2009, f. & cert. ef. 10-1-09; Renumbered from
409-030-0000 by DMAP 1-2011, f. 2-10-11, cert. ef. 3-1-11
410-121-2005
General Administration
(1) The Administrator, or designee, may:
(a) Negotiate price discounts and rebates on
prescription drugs with prescription drug manufacturers;
(b) Purchase prescription drugs on behalf of enrollees
and participating groups;
(c) Contract with a prescription drug claims processor
or PBM to adjudicate pharmacy claims and transmit program prices to pharmacies;
(d) Determine program prices and reimburse pharmacies
for prescription drugs;
(e) Adopt and implement a preferred drug list for the
program;
(f) Develop a system for allocating and distributing
the operational costs of the program and any rebates obtained to participants
of the program; and
(g) Cooperate with any state or regional consortia in
bulk purchasing of prescription drugs.
(2) The Administrator shall oversee the implementation
of the OPDP, including review of enrollee eligibility information,
participating group information, and pharmacy provider compliance with program
requirements. The Administrator, or designated entity, shall review records or
other information, including health information, necessary to perform oversight
responsibilities.
(3) The Administrator shall establish processes, terms,
and conditions describing how the entities identified in ORS 414.312(4) may
participate in the OPDP as a participating group, including entities otherwise
subject to ORS 731.036(6).
(4) The Administrator may contract with a pharmacy
benefit manager directly or indirectly for pharmacy networks that provide
statewide access for OPDP members including consideration for CAP providers.
(5) The Administrator may contract with replenishment
administrators, GPO’s or 340B providers as necessary to utilize discount
purchasing programs.
(6) Annually, no later than November 1, the Office of
Rural Health shall determine any Oregon pharmacies that meet CAP status and
report them to the OPDP for CAP designation. OPDP shall send the current list
of all Oregon retail pharmacies to the Office of Rural Health no later than
October l each year.
Stat. Auth.: ORS 414.320
Stats. Implemented: ORS 414.312 -
414.320
Hist.: OHP 1-2004, f. & cert.
ef. 9-24-04; OHP 2-2006(Temp), f. & cert. ef. 11-28-06 thru 5-23-07;
Administrative Correction, 6-16-07; OHP 3-2007, f. & cert. ef. 8-3-07; OHP
3-2009, f. & cert. ef. 10-1-09; Renumbered from 409-030-0005 by DMAP
1-2011, f. 2-10-11, cert. ef. 3-1-11
410-121-2010
Pharmacy Providers
(1) The pharmacy shall contract with the Department, or
its designated entity, and must be licensed with their state Board of Pharmacy
to be a pharmacy provider under the OPDP.
(2) The pharmacy provider shall sign a pharmacy
provider contract and comply with all applicable state and federal laws,
regulations, rules, and the terms and conditions of the contract. The contract
authorizes the pharmacy to serve enrollees in the OPDP and outlines program
compliance requirements.
(3) A contract may be issued to a qualified pharmacy
provider upon:
(a) Completion and signature of the contract by the
pharmacy provider or a person authorized by the pharmacy provider to bind the
organization;
(b) Verification of pharmacy licensing with the Oregon
Board of Pharmacy; and
(c) Approval of the contract by the Department or its
designated entity.
(4) To contract for the OPDP, the pharmacy provider
must:
(a) Accept the program price in effect on the date of
the transaction as established by the Administrator including but not limited
to dispensing fees which may be charged to the enrollee;
(b) Maintain sufficient documentation of transactions
to resolve disagreements with the enrollee about the amount charged for the
prescription drugs;
(c) Reimburse the enrollee or participating group
directly for overcharges as determined by program price in effect on the date
of the transaction;
(d) Provide access to records and data required by the
designated entity to administer claims, reimbursement, and other tasks as
necessary for OPDP claims processing; and
(e) Not charge enrollees for costs incurred by the
pharmacy provider for the electronic transmittal of the program price from the
Department to the pharmacy.
(5) Pharmacy providers may advertise participation in
the OPDP;
(a) Advertising or marketing materials must be accurate
and not misleading or confusing to enrollees or the public about participation
in the OPDP or the savings offered by the pharmacy provider.
(b) The pharmacy provider must cease all advertisements
pertaining to participation in the program if the Department suspends or
terminates the contract.
(6) The Administrator shall, at its discretion, suspend
or remove a pharmacy provider from the OPDP if the pharmacy provider loses
licensure or fails to comply with applicable state and federal laws, rules, and
regulations, and the terms and conditions of the contract.
Stat. Auth.: ORS 414.320
Stats. Implemented: ORS 414.312 -
414.320
Hist.: OHP 1-2004, f. & cert.
ef. 9-24-04; OHP 2-2007(Temp), f. & cert. ef. 5-16-07 thru 11-6-07; OHP
3-2007, f. & cert. ef. 8-3-07; OHP 3-2009, f. & cert. ef. 10-1-09;
Renumbered from 409-030-0010 by DMAP 1-2011, f. 2-10-11, cert. ef. 3-1-11
410-121-2020
Program Price
(1) The price for a prescription drug a pharmacy
provider may charge an enrollee under the OPDP is the lesser of the following
on the date of the transaction:
(a) The program price, or
(b) The pharmacy provider’s usual and customary price,
including program cost and dispensing fee.
(2) The designated entity shall transmit the price of
the prescription drugs to the pharmacy providers electronically.
(3) The OPDP is limited to prescription drugs
prescribed in the name of and for the use by the enrollee, except as otherwise
provided in section (7) of this rule.
(4) Prescription drug benefits shall be outlined on
enrollee and group enrollee identification cards.
(5) The OPDP does not include prescriptions for
over-the-counter drugs.
(6) The Administrator, or designated entity, may
establish different program prices for CAP providers in rural areas to maintain
statewide access to the OPDP.
(7) Certain participating groups may receive the
program price based on other reimbursement arrangements with the OPDP, where
the prescription drug is not being dispensed by a pharmacy provider to a group
enrollee. The designated entity shall approve and arrange such reimbursement.
Stat. Auth.: ORS 414.320
Stats. Implemented: ORS 414.312 -
414.320
Hist.: OHP 1-2004, f. & cert.
ef. 9-24-04; OHP 2-2006(Temp), f. & cert. ef. 11-28-06 thru 5-23-07; OHP
2-2007(Temp), f. & cert. ef. 5-16-07 thru 11-6-07; OHP 3-2007, f. &
cert. ef. 8-3-07; OHP 3-2009, f. & cert. ef. 10-1-09; Renumbered from
409-030-0020 by DMAP 1-2011, f. 2-10-11, cert. ef. 3-1-11
410-121-2030
Preferred Drug List
(1) The Office for Oregon Health Policy and Research
shall develop and recommend to the Administrator a PDL that identifies
preferred choices of prescription drugs within therapeutic classes for
particular diseases and conditions, including generic alternatives, for use in
the OPDP by participating groups.
(2) The OPDP shall develop a PDL that participating
groups may choose to adopt for beneficiaries of their prescription drug benefit
program. The PDL shall include the most effective prescription drugs at the
lowest possible prices, taking into account negotiated price discounts and
rebates available to the OPDP, while allocating and distributing the
operational costs of the OPDP.
(3) If a participating group uses the PDL developed by
the OPDP, it must be used in conjunction with that group’s benefit plan
including all pharmacy management programs the group has or adopts.
(4) The PDL shall also be made available to individuals
enrolled in the OPDP.
Stat. Auth.: ORS 414.320
Stats. Implemented: ORS 414.312 -
414.320
Hist.: OHP 1-2004, f. & cert.
ef. 9-24-04; OHP 3-2009, f. & cert. ef. 10-1-09; Renumbered from
409-030-0030 by DMAP 1-2011, f. 2-10-11, cert. ef. 3-1-11
410-121-2050
Enrollment
(1) Participating groups shall enroll for participation
through the designated entity chosen by the OPDP to administer the
participating group’s enrollment and claims processing.
(a) Eligibility for group enrollees of a participating
group shall be maintained electronically between the group and designated
entity.
(b) Participating groups shall issue identification
cards to group enrollees at initial enrollment and renewal, and to group
enrollees between those times as needed.
(2) Residents of Oregon who do not have prescription
drug coverage or who are underinsured for prescription drug coverage may be
individually enrolled by the designated entity.
(a) The designated entity shall issue Identification
cards to enrollees.
(b) Individuals who are eligible for Medicare Part D
prescription drug coverage may participate in the program.
(3) The OPDP may charge a nominal fee to participate in
the program.
Stat. Auth.: ORS 414.320
Stats. Implemented: ORS 414.312 -
414.320
Hist.: OHP 1-2004, f. & cert.
ef. 9-24-04; OHP 2-2006(Temp), f. & cert. ef. 11-28-06 thru 5-23-07; OHP
2-2007(Temp), f. & cert. ef. 5-16-07 thru 11-6-07; OHP 3-2007, f. &
cert. ef. 8-3-07; OHP 3-2009, f. & cert. ef. 10-1-09; Renumbered from
409-030-0050 by DMAP 1-2011, f. 2-10-11, cert. ef. 3-1-11
410-121-2065
Contracted Services
(1) The Administrator may procure goods and services to
perform any of the functions of OPDP.
(2) The Administrator shall delegate procurement
authority to the Department’s Designated Procurement Officer for OPDP goods and
services, except as the Administrator determines to retain such authority in a
particular case and as otherwise provided in section (4) of this rule.
(3) The Administrator shall act as the Department’s
representative for each contract. The Administrator may delegate in writing the
representative’s responsibilities to a designee. The agency’s representative
may participate with the Department’s Designated Procurement Officer in all
aspects of procurement.
(4) OPDP’s mechanism for and administration of the
enrollment of participating groups shall not constitute procurements subject to
this rule.
Stat. Auth.: ORS 409.050 &
414.312
Stats. Implemented: ORS 414.312,
414.314, 414.316 & 414.318
Hist.: OHP 3-2007, f. & cert.
ef. 8-3-07; OHP 3-2009, f. & cert. ef. 10-1-09; OHP 2-2010(Temp) f.
4-20-10, cert. ef. 4-21-10 thru 10-17-10; OHP 6-2010, f. 9-23-10, cert. ef.
10-1-10; Renumbered from 409-030-0065 by DMAP 1-2011, f. 2-10-11, cert. ef.
3-1-11
Notes
1.) This online version of the OREGON BULLETIN is provided for convenience of reference and enhanced access. The official, record copy of this publication is contained in the original Administrative Orders and Rulemaking Notices filed with the Secretary of State, Archives Division. Discrepancies, if any, are satisfied in favor of the original versions. Use the OAR Revision Cumulative Index found in the Oregon Bulletin to access a numerical list of rulemaking actions after November 15, 2010.
2.) Copyright 2011 Oregon Secretary of State: Terms and Conditions of Use |